Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.

Rationale: Ropanicant (SUVN-911) (3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo (3.1.0) hexane hydrochloride) is a novel α4β2 nicotinic acetylcholine receptor (nAChR) antagonist being developed for the treatment of depressive disorders. Objectives: Pharmacological and neurochemical characterizatio...

Full description

Bibliographic Details

Published in:	Psychopharmacology Vol. 239; no. 7; pp. 2215 - 2233
Main Authors:	Nirogi, Ramakrishna, Abraham, Renny, Jayarajan, Pradeep, Goura, Venkatesh, Kallepalli, Rajesh, Medapati, Rajesh babu, Tadiparthi, Jayaprakash, Goyal, Vinod kumar, Pandey, Santosh kumar, Subramanian, Ramkumar, Petlu, Surendra, Thentu, Jagadeesh Babu, Palacharla, Veera Raghava Chowdary, Gagginapally, Shankar Reddy, Mohammed, Abdul Rasheed, Jasti, Venkat
Format:	Journal Article
Published:	Springer Nature Jul2022
Online Access:	View this record in EBSCOhost